Atrophy of vulva
ICD-10 N90.5 is a billable code used to indicate a diagnosis of atrophy of vulva.
Atrophy of the vulva refers to the thinning and shrinking of the vulvar tissues, which can occur due to various factors, including hormonal changes, particularly during menopause. This condition is characterized by a decrease in the elasticity and moisture of the vulvar skin, leading to symptoms such as dryness, irritation, and discomfort. Atrophy can also result in a reduction of the vulvar fat pad, which may contribute to pain during intercourse (dyspareunia) and increased susceptibility to trauma and infections. The condition is often associated with other noninflammatory disorders of the female genital tract, such as vaginal atrophy, which is a similar process affecting the vaginal walls. Clinicians may encounter atrophy of the vulva in patients with a history of estrogen deficiency, such as postmenopausal women or those undergoing certain cancer treatments. Diagnosis typically involves a thorough clinical examination and may require a review of the patient's hormonal status. Treatment options may include topical estrogen therapy, moisturizers, and lifestyle modifications to alleviate symptoms and improve quality of life.
Detailed patient history, including hormonal status and symptom description.
Postmenopausal women presenting with vulvar dryness and discomfort.
Consideration of other vulvar disorders that may present similarly.
Skin examination findings and any relevant biopsy results.
Patients with vulvar skin changes needing differentiation from inflammatory conditions.
Need for thorough differential diagnosis to rule out other dermatological issues.
Used during follow-up visits for patients with vulvar atrophy.
Document patient history, examination findings, and treatment plan.
Gynecologists should ensure comprehensive documentation to support the visit level.
Common symptoms include dryness, irritation, itching, and pain during intercourse. Patients may also report changes in vulvar appearance.
